abstract |
The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods of inhibiting the activity of FGFR enzymes by the compounds and compositions of the present invention. The present invention also relates to, but is not limited to, methods of treating disorders related to FGFR signaling by means of the compounds and compositions of the present invention. |